These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Value of nicergoline in postischemic cerebral resuscitation. An experimental study in the dog]. Cahn R; Weber S; Angignard J; Angignard D; Borzeix MG Agressologie; 1987 Mar; 28(3):341-6. PubMed ID: 3618895 [No Abstract] [Full Text] [Related]
43. [Effectiveness of nicergoline in the treatment of chronic cerebrovascular insufficiency (author's transl)]. Kaemmerer E Nervenarzt; 1980 Jun; 51(6):368-72. PubMed ID: 7453888 [No Abstract] [Full Text] [Related]
44. [Importance of improving sympathetic tonus in the medical treatment of impotence with vascular disorders: clinical and ultrasonic study of the action of nicergoline]. Chomant J; de Somer-Leroy R; Boismare F; Boquet J; Ozenne G; Schrub JC LARC Med; 1982 Sep; 2(8):717-9. PubMed ID: 7162273 [No Abstract] [Full Text] [Related]
45. Nicergoline in the treatment of neuropathic bladder dysfunction: a preliminary report. Gallego J; Forner V; Jimenez F; Martinez E Paraplegia; 1984 Aug; 22(4):216-24. PubMed ID: 6483464 [TBL] [Abstract][Full Text] [Related]
46. [Hemodynamic study of (nicergoline) about left ventricular heart failure (author's transl)]. Drobinski G; Komajda M; Evans JI; Vedel J; Eugene M; Grosgogeat Y Ann Cardiol Angeiol (Paris); 1981 May; 30(3):211-4. PubMed ID: 7283363 [No Abstract] [Full Text] [Related]
47. Double-blind, placebo-controlled study of nicergoline in the treatment of pruritus in patients receiving maintenance hemodialysis. Bousquet J; Rivory JP; Maheut M; Michel FB; Mion C J Allergy Clin Immunol; 1989 Apr; 83(4):825-8. PubMed ID: 2708742 [TBL] [Abstract][Full Text] [Related]
48. [Interaction between anti-aggregating and anticoagulant agents. A double blind study on the concomitant administration of nicergoline and acenocoumarols]. Pogliani E; Recalcati P; Tantalo V; Bregnani P Arzneimittelforschung; 1979; 29(8a):1266-9. PubMed ID: 395954 [TBL] [Abstract][Full Text] [Related]
49. Clinical evaluation of (-)eburnamonine in comparison with nicergoline in patients suffering from chronic brain ischemia. Marolda M; Fragassi N; Buscaino GA Eur Neurol; 1978; 17 Suppl 1():159-66. PubMed ID: 381006 [TBL] [Abstract][Full Text] [Related]
50. [Rheographic study of nicergolin in the circulation of the lower limbs in healthy and arteriopathic subjects]. Boismare F; Philippe JC; Leduc X Therapie; 1974; 29(6):925-32. PubMed ID: 4618389 [No Abstract] [Full Text] [Related]
51. [Advantage of nicergoline after cardiac surgery in an adult (author's transl)]. Zerr C; Fauchon G; Lebreton P; Khayat A; Maiza D; Quesnel J Anesth Analg (Paris); 1981; 38(11-12):621-6. PubMed ID: 7114512 [TBL] [Abstract][Full Text] [Related]
52. [Hemodynamic effects of an alpha-blocking vasodilator in cardiac insufficiency caused by left-right shunt in children]. Cloez JL; Isaaz K; Marchal C; Morizot D; Pernot C Arch Mal Coeur Vaiss; 1986 May; 79(5):677-82. PubMed ID: 3092767 [TBL] [Abstract][Full Text] [Related]
53. [The effects of nicergoline on the heart rate in the normotensive or spontaneously hypertensive rat. Possible participation of central alpha-1 receptors]. Huchet AM; Schmitt H J Pharmacol; 1986; 17(1):53-9. PubMed ID: 3012204 [TBL] [Abstract][Full Text] [Related]
54. [Neurophysiological study of 36 patients with cerebral vascular processes treated with nicergoline (author's transl)]. Samsó Dies JM; Villa Badó J; Villalobos J; Iriarte JL; Ordeix R Arzneimittelforschung; 1979; 29(8a):1301-7. PubMed ID: 540075 [TBL] [Abstract][Full Text] [Related]
55. [Therapeutic trial in acute cochlear deafness. A comparative study of Ginkgo biloba extract and nicergoline]. Dubreuil C Presse Med; 1986 Sep; 15(31):1559-61. PubMed ID: 2947099 [TBL] [Abstract][Full Text] [Related]
56. Animal model of anxiety: effect of nicergoline in the genetically hypertensive rats of Koletsky type and in the rats of Wistar strain. Golda V; Petr R Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1989; 32(1):109-20. PubMed ID: 2799259 [TBL] [Abstract][Full Text] [Related]
57. [Evaluation of the effectiveness and tolerance of the preparation Sermion in the treatment of selected retinal diseases]. Szaflik J; Jupowiecka A Klin Oczna; 1985 Apr; 87(4):165-6. PubMed ID: 3900547 [No Abstract] [Full Text] [Related]
58. [Pharmacological study of nicergoline. (II). Protective effect on ischemic brain damages in animals]. Shintomi K; Itakura T; Yoshimoto K; Ogawa Y; Fukushima T; Matsuoka Y Nihon Yakurigaku Zasshi; 1986 Apr; 87(4):427-34. PubMed ID: 3755114 [TBL] [Abstract][Full Text] [Related]
59. [Initial dyscirculatory encephalopathy in middle-aged and elderly patients (problems of early diagnosis and therapy)]. Man'kovskiĭ NB; Mints AIa; Karaban' IN Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(1):16-20. PubMed ID: 2718657 [TBL] [Abstract][Full Text] [Related]
60. [Electroencephalography and psychometric measurements during the treatment of cerebral insufficiency with nicergoline and dihydroergotamine mesylate]. Kugler JE; Meurer-Krüll BC Arzneimittelforschung; 1985; 35(12):1865-70. PubMed ID: 3913425 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]